Clinical review and implications of the guideline for the early management of patients with acute ischemic stroke

AACN Advanced Critical Care

Volumn 25, Issue 2, 2014, Pages 130-141

  Livesay, Sarah L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

clinical practice guideline; ischemic stroke; stroke; stroke protocol; stroke system

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; BRAIN ISCHEMIA; HUMAN; PRACTICE GUIDELINE; STROKE; TOTAL QUALITY MANAGEMENT;

ACUTE DISEASE; ANTICOAGULANTS; BRAIN ISCHEMIA; HUMANS; NEUROPROTECTIVE AGENTS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; STROKE;

EID: 84899847360     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0000000000000017     Document Type: Review

References (32)

1. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44 (3): 870 - 947
2. Ovbiagele B, Goldstein LB, Higashida RT, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013; 44 (8): 2361 - 2375
3. Adams HP, Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007; 115 (20): e478 - e534
4. Lin CB, Peterson ED, Smith EE, et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circulation. 2012; 5 (4): 514 - 522
5. Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ. Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol. 2013; 70 (9): 1126 - 1132
6. Schwamm LH, Audebert HJ, Amarenco P, et al. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009; 40 (7): 2635 - 2660
7. Fonarow GC, Smith EE, Saver JL, et al. Improving doorto- needle times in acute ischemic stroke: the design and rationale for the American Heart Association/ American Stroke Association's Target: Stroke initiative. Stroke. 2011; 42 (10): 2983 - 2989
8. Sheth KN, Terry JB, Nogueira RG, et al. Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes. J Neurointervent Surg. 2013; 5 (Suppl 1): i62 - i65
9. Fisher M, Albers GW. Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol. 2013; 73 (1): 4 - 9
10. Green DM, O'Phelan KH, Bassin SL, Chang CW, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care. 2010; 13 (3): 299 - 306
11. Rosso C, Corvol JC, Pires C, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. 2012; 43 (9): 2343 - 2349
12. Southerland AM, Johnston KC. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Ann N York Acad Sci. 2012; 1268: 72 - 78
13. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359 (13): 1317 - 1329
14. Barreto AD. Intravenous thrombolytics for ischemic stroke. Neurotherapeutics. 2011; 8 (3): 388 - 399
15. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007; 38 (9): 2612 - 2618
16. Folyovich A, Varga V, Beres-Molnar KA, Vadasdi K, Bereczki D. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant. J Stroke Cerebrovasc Dis. 2013;pii: S1052-3057(13)00150-X
17. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368 (10): 893 - 903
18. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368 (10): 904 - 913
19. Pierot L, Soderman M, Bendszus M, et al. Statement of ESMINT and ESNR regarding recent trials evaluating the endovascular treatment at the acute stage of ischemic stroke. Neuroradiology. 2013; 55 (11): 1313 - 1318
20. Sacks D, Connors JJ, III Black CM. Society of Interventional Radiology Position Statement on endovascular acute ischemic stroke interventions. J Vasc Interv Radiol. 2013; 24 (9): 1263 - 1266
21. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42 (1): 227 - 276
22. Chatterjee S, Maitra S, Chakraborty A. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2012; 163 (1): e1; author reply e3
23. Benavente OR, White CL, Pearce L, et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke. 2011; 6 (2): 164 - 175
24. Palacio S, Hart RG, Pearce LA, Benavente OR. Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke. 2012; 43 (8): 2157 - 2162
25. Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-II: neurologic outcome and efficacy analysis. Stroke. 2006; 37 (8): 2107 - 2114
26. Silva GS, Schwamm LH. Review of stroke center effectiveness and other Get With The Guidelines data. Curr Atheroscler Rep. 2013; 15 (9): 1 - 8
27. Donnellan C, Sweetman S, Shelley E. Health professionals' adherence to stroke clinical guidelines: a review of the literature. Health Policy. 2013; 111 (3): 245 - 263
28. Middleton S, McElduff P, Ward J, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011; 378 (9804): 1699 - 1706
29. Donnellan C, Sweetman S, Shelley E. Implementing clinical guidelines in stroke: a qualitative study of perceived facilitators and barriers. Health Policy. 2013; 111 (3): 234 - 244
30. Schwamm LH, Pancioli A, Acker JE III, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke. 2005; 36 (3): 690 - 703
31. Sacks D, Connors JJ, III Black CM. Society of interventional radiology position statement on endovascular acute ischemic stroke interventions. J Vasc Interv Radiol. 2013; 24 (9): 1263 - 1266
32. Mead GE, Cowey E, Murray SA. Life after stroke-is palliative care relevant? A better understanding of illness trajectories after stroke may help clinicians identify patients for a palliative approach to care. Int J Stroke. 2013; 8 (6): 447 - 448.